- Worldwide Delivery4-7 business days
- Quality GuaranteedOnly original products
- Bonus pillsSave up to 80%
- 24/7 SupportOur team of pharmacists is available 24/7 to help you
Women with androgen-related acne, unwanted facial or body hair, or irregular periods may be prescribed Diane 35 after an individual medical assessment. Diane 35 combines hormonal effects that reduce androgen activity, improve selected skin symptoms, and provide contraceptive protection when taken correctly.
Product information
Diane 35 is a combined hormonal medicine in tablet form. Its active ingredients are cyproterone acetate and ethinylestradiol, also written as ethinyl estradiol.
How it affects the body
Cyproterone acetate reduces the effect of androgens, hormones that can stimulate excess sebum, acne, and unwanted hair growth. Ethinylestradiol suppresses ovulation and helps stabilise hormonal fluctuations.
- Cyproterone acetate: blocks androgen activity at target tissues and reduces androgen-driven stimulation of the sebaceous glands and hair follicles.
- Ethinylestradiol: suppresses ovulation, changes cervical mucus, and supports the contraceptive effect of the combined hormonal regimen.
- Combined action: may improve acne, reduce androgen-related hair growth over time, and make withdrawal bleeding more predictable.
The European Medicines Agency has reviewed cyproterone acetate and ethinylestradiol combinations in relation to their benefits, indications, and thromboembolic risks [1].
Ingredients
Diane 35 is a combined hormonal medicine in tablet form. Its active ingredients are cyproterone acetate and ethinylestradiol, also written as ethinyl estradiol.
Dosage and administration
The standard Diane 35 regimen uses one tablet daily for 21 consecutive days, followed by a tablet-free interval directed by the prescriber or approved product information. The next course begins on schedule, even when bleeding has not completely stopped.
- Take one tablet at approximately the same time each day.
- Swallow it with water.
- An evening dose after food may reduce nausea for some women.
- Keep the dosing time consistent from one day to the next.
- Start the first course according to the prescribed plan, especially when changing from another hormonal method.
- Follow individual instructions when starting after pregnancy, childbirth, breastfeeding, or a different contraceptive.
The correct first-start method depends on the menstrual cycle and any previous hormonal contraception. Starting at the wrong point can leave uncertainty about contraceptive protection.
If vomiting occurs soon after taking a tablet, or severe diarrhoea continues, absorption may be incomplete. Treat the situation as a possible missed tablet and use the approved missed-dose instructions for the regimen.
When not to use it
Conditions requiring careful assessment include:
- Previous deep-vein thrombosis or pulmonary embolism.
- Stroke, transient ischaemic attack, or significant cardiovascular disease.
- Migraine with aura or new neurological migraine symptoms.
- Uncontrolled high blood pressure.
- Serious liver disease or liver tumours.
- Hormone-sensitive breast or reproductive cancers.
- Major surgery or prolonged immobility.
- Smoking, obesity, increasing age, or a strong family history of thrombosis.
- Unexplained vaginal bleeding.
- Medicines that induce liver enzymes.
Oestrogen-containing hormonal medicines can increase venous thromboembolism risk. The absolute risk is uncommon, yet the risk assessment becomes more important when several risk factors occur together. WHO contraceptive guidance and EMA safety reviews support individual assessment before prescribing combined hormonal medicines [2].
When this is not for you
Diane 35 is not suitable for every woman. This medication is not for you if you have a current or previous blood clot, a clotting disorder that increases thrombosis risk, stroke, migraine with aura, uncontrolled hypertension, serious liver disease, or a hormone-sensitive cancer for which oestrogen-containing treatment is unsuitable.
Avoid Diane 35 during pregnancy or suspected pregnancy. Breastfeeding also requires a specific clinical assessment because combined hormonal treatment may affect milk production and is not suitable in every postpartum situation.
Possible side effects
Possible side effects include nausea, stomach pain, headache, breast pain, mood changes, and perceived weight gain. Early nausea or breast tenderness may settle as the body adjusts. Weight changes are not always caused by permanent fat gain; fluid retention, appetite changes, menstrual changes, and unrelated factors can contribute.
Practical measures include:
- Taking the tablet after food if nausea occurs.
- Maintaining regular meals and hydration.
- Recording headaches and mood changes rather than relying on memory.
- Reporting persistent breast pain or a new breast lump.
- Seeking assessment for depression, marked anxiety, or severe mood deterioration.
- Discussing troublesome symptoms before stopping or restarting treatment.
A new severe headache is not an ordinary nuisance symptom when it is sudden, persistent, or associated with weakness, confusion, speech difficulty, or visual symptoms. Headache patterns can also change when blood pressure rises or migraine with aura develops.
Therapeutic indications
Diane 35 may be prescribed for acne, excessive hair growth, and irregular periods linked with androgen excess. These symptoms can occur with polycystic ovary syndrome, also known as PCOS. Diane 35 can manage selected PCOS symptoms, but it does not remove the underlying metabolic or hormonal causes of PCOS.
Its clinical uses include:
- Androgen-related acne: reduced androgen stimulation can decrease oil production and inflammatory breakouts.
- Excessive hair growth: facial or body hair may become less prominent as androgen effects decline, although improvement is slow because existing hair follows its normal growth cycle.
- Irregular periods: hormonal suppression can create a more predictable bleeding pattern.
- PCOS-related symptoms: Diane 35 may help selected symptoms but does not cure PCOS.
- Contraception: ovulation suppression provides contraceptive protection when the regimen is followed correctly.
| Symptom | Expected change | Medical review |
|---|---|---|
| Acne | Fewer inflammatory breakouts after continued treatment | Review persistent or worsening acne |
| Excessive hair growth | Slower new growth over several cycles | Review rapid or severe hair growth |
| Irregular periods | More predictable withdrawal bleeding | Assess absent, heavy, or painful bleeding |
Acne treatment may require patience. Hormonal treatment also needs periodic review once symptoms are controlled, because continued use should reflect the woman’s current medical needs and risk profile.
Comparison
Diane 35 has a distinct role because it combines contraception with anti-androgen treatment. A standard combined oral contraceptive pill may provide contraception without the same anti-androgen emphasis. Non-hormonal contraception avoids oestrogen exposure but does not treat acne, excessive hair growth, or irregular periods.
| Option | Main role | Main limitation |
|---|---|---|
| Diane 35 | Contraception plus treatment of selected androgen-related symptoms | Hormonal and clotting risks require individual assessment |
| Standard combined oral contraceptive pill | Contraception and cycle control | Anti-androgen benefits vary by formulation |
| Non-hormonal contraception | Pregnancy prevention without combined hormones | Does not treat acne, hirsutism, or PCOS-related cycle symptoms |
For PCOS-related acne or excessive hair growth, Diane 35 may be considered when contraception is also appropriate. It is not a universal solution for PCOS, and metabolic issues such as insulin resistance still require separate clinical management.
Treatment decisions balance symptom benefit against contraindications, blood-pressure findings, clotting risk, migraine history, age, smoking, and other medicines. MOHAP guidance and international contraceptive standards support this risk-based approach.
Common mistakes
Common mistakes can reduce contraceptive protection or delay recognition of a serious problem.
- Starting without a medical review: migraine with aura, previous thrombosis, high blood pressure, and liver disease can change suitability.
- Combining Diane 35 with another contraceptive pill: duplicate hormonal treatment can increase adverse effects.
- Restarting after a long gap without considering pregnancy: pregnancy should be excluded when clinically appropriate.
- Ignoring repeated headaches: a new or severe headache may require urgent assessment.
- Treating persistent spotting as harmless: repeated bleeding, pain, odour, or pregnancy possibility needs review.
- Forgetting interacting medicines: enzyme-inducing medicines and St John’s wort can reduce contraceptive reliability.
- Stopping and restarting unpredictably: irregular use can produce bleeding changes and uncertain protection.
Track missed tablets, bleeding dates, mood changes, headaches, blood-pressure readings when monitored, and any new medication. These details make clinical review more precise.
What doctors say
In clinical practice, prescribers usually assess the reason for treatment before focusing on the contraceptive effect. Diane 35 is most useful when androgen-related acne, excessive hair growth, or cycle disturbance is a meaningful problem and the woman has no major contraindication to combined hormonal treatment.
A doctor will usually ask about migraine, smoking, blood clots, family history, blood pressure, liver disease, pregnancy possibility, breastfeeding, and current medicines. Symptoms may improve gradually, and hair-related changes often take longer than acne changes because hair follicles grow in cycles. Blood pressure should be checked before prescribing. Follow-up should reassess symptom response and emerging risk factors.
Diane 35 should be reviewed when symptoms are controlled. Continuing treatment without reassessing the original indication can expose a woman to hormonal risks without a clear ongoing benefit.
Common questions
How long does a Diane 35 course last, and is long-term use acceptable?
A usual course follows 21 days of tablets and a prescribed tablet-free interval, with the next course started on schedule. The total duration depends on the original problem, response, age, and clotting risk. EMA safety information and WHO contraceptive guidance from 2015 support periodic reassessment rather than automatic indefinite continuation. Long-term use may be appropriate for some women, while others need a different plan after acne or hair symptoms improve.
What should I do if the expected result does not appear?
Allow sufficient time for gradual improvement, especially with excessive hair growth, because hair follicles respond slowly. Persistent acne, worsening hair growth, or continued irregular bleeding should prompt a review of the diagnosis, adherence, interacting medicines, and other causes. NICE guidance updated in 2023 supports reassessment when acne does not respond to an appropriate treatment plan. Do not increase the dose or combine hormonal products independently.
Which concrete condition rules Diane 35 out?
A current or previous venous blood clot is a clear example of a condition that can rule out Diane 35. Migraine with aura, serious liver disease, stroke, and some hormone-sensitive cancers can also make it unsuitable. WHO eligibility guidance published in 2015 places strong restrictions on combined hormonal contraception in several of these situations. A history of clotting must be stated before treatment begins.
What should be checked before starting Diane 35?
The prescriber should review pregnancy possibility, blood pressure, migraine type, personal and family clotting history, smoking, obesity, planned surgery, liver disease, breastfeeding, and all medicines. The reason for using Diane 35 should also be clear, since contraception alone may not justify this anti-androgen combination in every patient. MOHAP is the relevant health authority in the UAE, while the EMA's 2013 safety review provides European regulatory context. Bring a complete medicine and supplement list to the appointment.
Can alcohol be used while taking Diane 35?
Alcohol does not directly cancel the contraceptive action of Diane 35, but heavy drinking can make missed tablets, vomiting, and poor adherence more likely. Alcohol can also worsen nausea, headaches, mood changes, or liver strain in susceptible people. WHO contraceptive guidance from 2015 does not identify ordinary alcohol use as a direct contraceptive interaction. Vomiting soon after a tablet should be handled as a possible missed dose.
How long does one Diane 35 tablet keep working?
One tablet is designed to contribute to the daily hormonal regimen, not to provide a separate long-lasting contraceptive event that can be used independently. Protection depends on regular daily dosing, the previous cycle, and whether tablets have been missed. EMA product information published in 2013 for combined hormonal regimens explains why missed tablets can reduce protection. Do not treat a delayed tablet as interchangeable with emergency contraception.
What is the best time of day to take Diane 35?
Take Diane 35 at the same time each day. Evening use after food may help women who experience nausea, while morning use may suit someone who has a reliable breakfast routine. WHO guidance from 2015 supports consistent daily use for combined oral contraception, but it does not require one universal clock time. Choose a time that makes missed tablets less likely and keep it consistent.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Sources
- European Medicines Agency (2013). Summary of Product Characteristics (SmPC) — cyproterone acetate/ethinylestradiol.
- World Health Organization (2015). Medical eligibility criteria for contraceptive use, Fifth edition.